Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Burns ; 49(5): 1181-1195, 2023 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-36116995

RESUMO

Owing to the high level of resistance to various antibiotics in bacteria causing burn wound infections, the alternative therapeutics is highly demanded. Bdellovibrio and like organisms (BALOs) seem to be a superb choice. In the present study, Bdellovibrio bacteriovorus HD100 was selected for treating burn wound infection caused by Pseudomonas aeruginosa strain PAO1 in a mouse model. In this experiment, two treatments, meropenem as antibiotic and B. bacteriovorus, were employed. Histopathology indicated an accelerated healing rate in both treatments in comparison with the control. Moreover, quantitative reverse transcription PCR (qRT-PCR) was applied to investigate the expression of tnf-α (tumor necrosis factor alpha), pdgf (platelet-derived growth factor), tgf-ß1 (transforming growth factor beta1), ifn-γ (interferon gamma), vegf (vascular endothelial group factor), and col1 (collagen type 1). The results demonstrated that treating burn wound areas with Bdellovibrio not only decrease the inflammatory phase period, but also may improve the characteristics of proliferative phases of wound healing. In addition, a significant difference was explored between the two treatment groups in the regulation of all genes, except for pdgf revealed a significant up regulation in both treatment groups. The results disclose that Bdellovibrio attenuates P. aeruginosa in burn wounds infections and improves the wound healing process.


Assuntos
Bdellovibrio bacteriovorus , Bdellovibrio , Queimaduras , Infecção dos Ferimentos , Animais , Camundongos , Bdellovibrio bacteriovorus/fisiologia , Queimaduras/terapia , Bdellovibrio/genética , Pseudomonas , Infecção dos Ferimentos/terapia
2.
Neuroreport ; 18(7): 675-8, 2007 May 07.
Artigo em Inglês | MEDLINE | ID: mdl-17426597

RESUMO

Central nucleus of the amygdala is involved in cardiovascular regulation. Although most components of the renin-angiotensin system have been found to be distributed in amygdala, renin expression in brain has remained controversial. This work was undertaken to elucidate the extent of renin presence in this nucleus. A cannula was implanted bilaterally into the central nucleus of the amygdala. Mean arterial pressure and heart rate were directly measured via indwelling femoral artery cannula post bilateral intra central nucleus of the amygdala microinjection of renin substrate. Renin substrate microinjection dose-dependently increased mean arterial pressure and heart rate, whereas captopril, saralasin and losartan pretreatment inhibited these effects. The results suggest the presence of local renin or similar proteases in this nucleus.


Assuntos
Tonsila do Cerebelo/metabolismo , Angiotensinogênio/administração & dosagem , Sistema Cardiovascular/efeitos dos fármacos , Inibidores de Serina Proteinase/administração & dosagem , Tonsila do Cerebelo/efeitos dos fármacos , Angiotensinogênio/metabolismo , Animais , Pressão Sanguínea/efeitos dos fármacos , Sistema Cardiovascular/metabolismo , Relação Dose-Resposta a Droga , Frequência Cardíaca/efeitos dos fármacos , Injeções Intraventriculares , Masculino , Microinjeções , Ratos , Ratos Sprague-Dawley , Renina/metabolismo , Inibidores de Serina Proteinase/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...